Press Releases

    Print Page  Close Window
BioMed Realty Trust Announces Tax Treatment of 2006 Distributions

SAN DIEGO, Jan. 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2006 distributions as follows:

                      Security Description: Common Stock
                               CUSIP: 09063H107
                              Ticker Symbol: BMR

                               Total                  Taxable
     Record       Payable   Distribution  Allocable   Ordinary    Return of
      Date         Date      Per Share     to 2006    Dividend     Capital
    12/30/2005   1/16/2006   $0.270000    $0.205722   $0.203580   $0.002142
     3/31/2006   4/17/2006   $0.290000    $0.290000   $0.286980   $0.003020
     6/30/2006   7/17/2006   $0.290000    $0.290000   $0.286980   $0.003020
     9/29/2006  10/16/2006   $0.290000    $0.290000   $0.286980   $0.003020
           Totals            $1.140000    $1.075722   $1.064520   $0.011202

The distributions payable on January 16, 2007 to shareholders of record on December 29, 2006 are considered 2007 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2006. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.004 per share attributable to depreciation, assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(TM). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry, and its properties and primary acquisition targets are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey. BioMed's real estate portfolio consists of 56 properties, representing 92 buildings with approximately 7.9 million rentable square feet in each of the major life science markets in the United States. Additional information is available at

SOURCE BioMed Realty Trust, Inc.

CONTACT: Kent Griffin, Chief Financial Officer of BioMed Realty Trust,
Inc., +1-858-485-9840
Web site: